A Study to Explore Association Patterns Between Digital Outcome Assessments From the Konectom™ Platform and Magnetic Resonance Imaging (MRI) Measures of Brain Tissue Damage

CompletedOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

December 15, 2021

Primary Completion Date

April 3, 2024

Study Completion Date

April 3, 2024

Conditions

Multiple Sclerosis (MS)

Interventions

DEVICE

Konectom platform

Administered as specified in the treatment arm.

Trial Locations (1)

Multiple Sclerosis Centre, Dresden